COMBINATION COMPRISING AN AT1-RECEPTOR ANTAGONIST AND AN INSULIN SECRETION ENHANCER OR AN INSULIN SENSITISER

摘要

The present invention relates to a combination, especially a pharmaceutical composition, comprising as active ingredients
(i) an AT₁-receptor antagonist or a pharmaceutically acceptable salt thereof;
(ii) (a) an insulin secretion enhancer or a pharmaceutically acceptable salt thereof or (b) an insulin sensitizer or a pharmaceutically acceptable salt thereof; and,

in case of a pharmaceutical composition, a pharmaceutically acceptable carrier.